Cargando…
Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results
Objective: Myeloid malignancies are heterogeneous disorders due to defective hematopoiesis and myeloid differentiation of hematopoietic stem/progenitor cell. The molecular landscape of the diseases is complex. Molecular alterations are used for classification and evaluation of prognosis and treatmen...
Autores principales: | Yuce Kahraman, Cigdem, Sincan, Gulden, Tatar, Abdulgani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atatürk University School of Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634881/ https://www.ncbi.nlm.nih.gov/pubmed/35703527 http://dx.doi.org/10.5152/eurasianjmed.2022.21102 |
Ejemplares similares
-
Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016) -
Intrasinusoidal proerythroblast infiltration in therapy related myeloid neoplasm
por: Li, Jian, et al.
Publicado: (2023) -
Atypical Presentation of Plasma Cell Neoplasm of the Sternum
por: Udongwo, Ndausung, et al.
Publicado: (2021) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
por: Nasiri, Abdulrahman, et al.
Publicado: (2023) -
Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
por: Shah, Nirmish, et al.
Publicado: (2019)